Companies / Fortress Biotech, Inc.

Fortress Biotech, Inc.

Nasdaq: FBIOCIK 1429260BAY HARBOR ISLANDS, FLfortressbiotech.com ↗

Financials · FY2025

Revenue$63.26M
Net income$-32.91M
Total debt$35.00M
Cash$196.58M
Diluted EPS$-0.07
Shares outstanding36.6M

Ownership

36.6M shares outstanding · as of May 11, 2026
20.6%Insiders
Ownership
90.6%Common Stock
Share classes
Common Stock90.65%
Common Stock9.35%
Insiders20.60%7,549,365
Institutions16.43%6,019,259
Public float62.97%23,077,586

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Lindsay A. Rosenwald, M.D.CEOPRESIDENT, CEO & CHAIRMAN · Director · 10% owner
12.52%4,586,841
Weiss Michael SExecutive Vice Chairman · Director
6.21%2,276,562
Lobell J JayDirector
0.53%192,397
Harvey JimmieDirector
0.40%146,704
Klein DovDirector
0.36%130,105
Hoenlein MalcolmDirector
0.32%115,747
Lorenz KevinDirector
0.28%101,009

Institutional holders 53

View all →
HolderValue% of shares
Vanguard Group Inc$4.03M3.00%
Opaleye Management Inc.$3.99M2.97%
Summit Financial, LLC$1.61M1.20%
Northern Trust Corp$876.7K0.65%
Susquehanna International Group, LLP$841.0K0.63%
Geode Capital Management, LLC$810.1K0.79%
BlackRock, Inc.$687.8K0.61%
Kestra Advisory Services, LLC$643.0K0.48%
Two Sigma Investments, LP$549.1K0.54%
Bridgeway Capital Management, LLC$508.8K0.50%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 1, 2026Lorenz Kevin
Director
Grantcommon stock, par value $0.001$0+27K
+37.08%
101,009
0.28% of shares
low
Jan 1, 2026Klein Dov
Director
Grantcommon stock, par value $0.001$0+27K
+26.58%
130,105
0.36% of shares
low
Jan 1, 2026Harvey Jimmie
Director
Grantcommon stock, par value $0.001$0+27K
+22.89%
146,704
0.40% of shares
low
Mar 18, 2026Weiss Michael S
Executive
Grantcommon stock, par value $0.001$0+475K
+26.40%
2,276,562
6.21% of shares
low
Mar 18, 2026Lindsay A. Rosenwald, M.D.
CEO
GrantCommon stock, par value $0.001$0+475K
+11.56%
4,586,841
12.52% of shares
low
Jan 1, 2026Hoenlein Malcolm
Director
GrantCommon Stock, par value $0.001$0+27K
+30.90%
115,747
0.32% of shares
low
Jan 1, 2026Lobell J Jay
Director
Grantcommon stock, par value $0.001$0+27K
+16.55%
192,397
0.53% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
FBIOCommon StockEquity34960Q307BBG001J2MFH6